Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris

J Drugs Dermatol
01 November 2017
https://pubmed.ncbi.nlm.nih.gov/29141063/

Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review

JAMA Dermatol
01 February 2019
https://pubmed.ncbi.nlm.nih.gov/30484835/

The uses of naltrexone in dermatologic conditions

J Am Acad Dermatol
June 2019
https://pubmed.ncbi.nlm.nih.gov/30582992/

Background: Naltrexone in standard and reduced doses is efficacious in many inflammatory and acantholytic disorders.

Objective: We summarized the current data of naltrexone that are relevant to dermatologic practice.

Inexpensive Compounding of Low-Dose Naltrexone With Orange Juice

J Am Acad Dermatol
28 March 2019
https://www.practiceupdate.com/content/inexpensive-compounding-of-low-d…

Inexpensive method to formulate low-dose naltrexone (LDN) at any local pharmacy by compounding full-dose naltrexone tablets into orange juice. This formulation can be dispensed with a dropper or mixed into a larger volume of juice.
 

The Use of Naltrexone in Dermatology. Current Evidence and Future Directions

Curr Drug Targets
2019
https://pubmed.ncbi.nlm.nih.gov/30887922/

The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial

J Dermatolog Treat
08 June 2020
https://pubmed.ncbi.nlm.nih.gov/32449418/

The Lowdown on Low-Dose Naltrexone

Cutis
January 2020

https://pubmed.ncbi.nlm.nih.gov/32074159/

 

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)